Market closed
Biodesix/$BDSX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Biodesix
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Ticker
$BDSX
Sector
Trading on
Industry
Health Care Providers & Services
Headquarters
Employees
273
ISIN
US09075X1081
Website
Biodesix Metrics
BasicAdvanced
$32M
-
-$0.29
-
-
Price and volume
Market cap
$32M
52-week high
$2.04
52-week low
$0.17
Average daily volume
1.3M
Financial strength
Current ratio
2.225
Quick ratio
1.896
Long term debt to equity
553.101
Total debt to equity
563.156
Interest coverage (TTM)
-4.37%
Management effectiveness
Return on assets (TTM)
-23.33%
Return on equity (TTM)
-1,454.41%
Valuation
Price to revenue (TTM)
0.42
Price to book
2.91
Price to tangible book (TTM)
-3.45
Price to free cash flow (TTM)
-0.691
Growth
Revenue change (TTM)
35.76%
Earnings per share change (TTM)
-46.61%
3-year revenue growth (CAGR)
32.26%
3-year earnings per share growth (CAGR)
-45.83%
What the Analysts think about Biodesix
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Biodesix stock.
Biodesix Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Biodesix Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Biodesix News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Biodesix stock?
Biodesix (BDSX) has a market cap of $32M as of May 17, 2025.
What is the P/E ratio for Biodesix stock?
The price to earnings (P/E) ratio for Biodesix (BDSX) stock is 0 as of May 17, 2025.
Does Biodesix stock pay dividends?
No, Biodesix (BDSX) stock does not pay dividends to its shareholders as of May 17, 2025.
When is the next Biodesix dividend payment date?
Biodesix (BDSX) stock does not pay dividends to its shareholders.
What is the beta indicator for Biodesix?
Biodesix (BDSX) does not currently have a Beta indicator.